TASR Stock Chart Sat, Feb 1st, 2014

New Post Public Reply Private Reply Replies (0) Message Board
chartguy89
TASR Stock Chart and Technical Analysis - Sat, Feb 1st, 2014 $TASR

Period  Moving Average  Price Change  Percent Change  Average Volume
5 Day  16.28  -0.68  -4.06%  979,580
20 Day  17.10  +0.68  +4.42%  1,382,470
50 Day  16.77  -1.02  -5.97%  1,237,184
100 Day  16.07  +3.91  +32.18%  1,511,232
200 Day  12.72  +8.13  +102.52%  1,092,469
Year to Date  17.02  +0.18  +1.13%  1,377,429

Period  Raw Stochastic  Stochastic %K  Stochastic %D  Average True Range
9 Day 9.29% 10.12% 13.04% 0.74
14 Day 9.03% 9.39% 13.57% 0.75
20 Day 21.45% 27.28% 32.93% 0.75
50 Day 29.32% 29.91% 33.81% 0.71
100 Day 58.77% 59.56% 62.05% 0.61

Period  Relative Strength  Percent R  Historic Volatility  MACD Oscillator
9 Day 38.36% 90.71% 39.69% -0.77
14 Day 42.92% 90.97% 44.36% -1.09
20 Day 45.72% 78.55% 61.58% -1.02
50 Day 51.25% 70.68% 51.92% -0.68
100 Day 53.89% 41.23% 57.72% +0.02

TASR Stock Chart and Technical Analysis - Sat, Feb 1st, 2014
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Lauletta Birnbaum Earns Distinction in 2026 Chambers Guide

Updated Category News Views 209

Lauletta Birnbaum Recognized in the 2026 Chambers Spotlight Guide Lauletta Birnbaum has received prestigious recognition in the 2026 Chambers Spotlight Guide in the category of Corporate/Commercial Law. This honor highlights the firm's commitment to providing exceptional legal services to its clients. The Importance of Legal Recognition Chambers and Partners is recognized...

Continue Reading
Medicenna Therapeutics Showcases Advances in Cancer Treatment

Updated Category News Views 127

Medicenna Therapeutics Showcases Advances in Cancer Treatment Medicenna Therapeutics Corp. is making notable strides in the field of cancer immunotherapy. With a focus on developing innovative therapies, the company is gaining attention for its promising Superkines targeting a range of conditions, including cancer. One of their leading programs, MDNA11, has showcased...

Continue Reading
DÉKUPLE Reports Strong Growth in First-Half Earnings 2024

Updated Category News Views 258

DÉKUPLE reported its first-half earnings for 2024, showcasing an 8.8% rise in net sales, totaling €104.6 million. The figures signal a resilient company navigating a turbulent economic backdrop, but traders are already weighing the potential fallout. Key Financial Metrics: Profitability vs. Economic Headwinds The group's gross margin jumped 5.8%, hitting €83.5...

Continue Reading
Main Street Capital Corporation Declares 2025 Dividend Increases

Updated Category News Views 220

Regular Monthly Dividends Announced by Main Street Capital Main Street Capital Corporation (NYSE: MAIN) has taken a significant step forward in announcing its regular monthly dividends for the early part of 2025. The Board of Directors has declared a monthly dividend of $0.25 per share for January, February, and March of that year. This move showcases the company's...

Continue Reading
Exciting New Travel Offers Just for Travelzoo Club Members

Updated Category News Views 306

Exclusive Travel Offers for Club Members Travelzoo® (NASDAQ: TZOO), a leading platform for travel enthusiasts, has rolled out an enticing set of offers tailored specifically for its Club Members. These deals are meticulously negotiated to provide the best experiences at the most competitive prices. Whether you're looking for adventure or relaxation, there's something for...

Continue Reading